Literature DB >> 23640805

O-GlcNAcomics--Revealing roles of O-GlcNAcylation in disease mechanisms and development of potential diagnostics.

Ronald J Copeland1, Guanghui Han2, Gerald W Hart2.   

Abstract

O-linked-β-N-acetylglucosamine (O-GlcNAc) is a dynamic PTM of the 3'-hydroxyl groups of serine or threonine residues of nuclear, cytoplasmic, and mitochondrial proteins. The cycling of this modification is regulated in response to nutrients, stress, and other extracellular stimuli by the catalytic activities of O-GlcNAc transferase and O-GlcNAcase. O-GlcNAc is functionally similar to phosphorylation and has been demonstrated to play critical roles in numerous biological processes, including cell signaling, transcription, and disease etiology. Since its discovery nearly 30 years ago, studies have demonstrated that the O-GlcNAc is highly abundant and widespread, like phosphorylation however, the development of methodologies to study O-GlcNAc at the site level has been challenging. Recently, a number of studies have overcome these challenges and describe new tagging, enrichment, and mass spectrometric-based approaches to study O-GlcNAc in terms of its site identification, stoichiometry, and dynamics on proteins. The development of these methods are key for elucidation of O-GlcNAc's functional crosstalk with phosphorylation and other PTMs, and will serve to provide the necessary information for the development of site-specific antibodies, which will aid in the determination of a particular protein's site-specific function. In this review, we describe these methods and summarize results obtained from them demonstrating the roles of O-GlcNAc in diabetes, cancer, Alzheimer's, and in learning and memory, while also describing how these new strategies have implicated O-GlcNAc as a potential diagnostic for the screening of patients for prediabetes.
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Alzheimer's; Cancer; Diabetes; Glycomics; O-GlcNAc

Mesh:

Substances:

Year:  2013        PMID: 23640805      PMCID: PMC3883918          DOI: 10.1002/prca.201300001

Source DB:  PubMed          Journal:  Proteomics Clin Appl        ISSN: 1862-8346            Impact factor:   3.494


  71 in total

1.  A chemoenzymatic approach toward the rapid and sensitive detection of O-GlcNAc posttranslational modifications.

Authors:  Nelly Khidekel; Sabine Arndt; Nathan Lamarre-Vincent; Alexander Lippert; Katherine G Poulin-Kerstien; Boopathy Ramakrishnan; Pradman K Qasba; Linda C Hsieh-Wilson
Journal:  J Am Chem Soc       Date:  2003-12-31       Impact factor: 15.419

2.  Exploring the O-GlcNAc proteome: direct identification of O-GlcNAc-modified proteins from the brain.

Authors:  Nelly Khidekel; Scott B Ficarro; Eric C Peters; Linda C Hsieh-Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-30       Impact factor: 11.205

Review 3.  Phosphofructokinase.

Authors:  K Uyeda
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1979

4.  A tissue-specific atlas of mouse protein phosphorylation and expression.

Authors:  Edward L Huttlin; Mark P Jedrychowski; Joshua E Elias; Tapasree Goswami; Ramin Rad; Sean A Beausoleil; Judit Villén; Wilhelm Haas; Mathew E Sowa; Steven P Gygi
Journal:  Cell       Date:  2010-12-23       Impact factor: 41.582

5.  Erythrocytes contain cytoplasmic glycoproteins. O-linked GlcNAc on Band 4.1.

Authors:  G D Holt; R S Haltiwanger; C R Torres; G W Hart
Journal:  J Biol Chem       Date:  1987-11-05       Impact factor: 5.157

6.  Mapping O-GlcNAc modification sites on tau and generation of a site-specific O-GlcNAc tau antibody.

Authors:  Scott A Yuzwa; Anuj K Yadav; Yuliya Skorobogatko; Thomas Clark; Keith Vosseller; David J Vocadlo
Journal:  Amino Acids       Date:  2010-08-13       Impact factor: 3.520

7.  The potential role of tau protein O-glycosylation in Alzheimer's disease.

Authors:  Laura A Robertson; Kenneth L Moya; Kieran C Breen
Journal:  J Alzheimers Dis       Date:  2004-10       Impact factor: 4.472

8.  Quantification of O-glycosylation stoichiometry and dynamics using resolvable mass tags.

Authors:  Jessica E Rexach; Claude J Rogers; Seok-Ho Yu; Jifang Tao; Yi E Sun; Linda C Hsieh-Wilson
Journal:  Nat Chem Biol       Date:  2010-07-25       Impact factor: 15.040

Review 9.  The cellular fate of glucose and its relevance in type 2 diabetes.

Authors:  Clara Bouché; Shanti Serdy; C Ronald Kahn; Allison B Goldfine
Journal:  Endocr Rev       Date:  2004-10       Impact factor: 19.871

10.  Monoclonal antibodies identify a group of nuclear pore complex glycoproteins.

Authors:  C M Snow; A Senior; L Gerace
Journal:  J Cell Biol       Date:  1987-05       Impact factor: 10.539

View more
  16 in total

1.  Human and rodent temporal lobe epilepsy is characterized by changes in O-GlcNAc homeostasis that can be reversed to dampen epileptiform activity.

Authors:  Richard G Sánchez; R Ryley Parrish; Megan Rich; William M Webb; Roxanne M Lockhart; Kazuhito Nakao; Lara Ianov; Susan C Buckingham; Devin R Broadwater; Alistair Jenkins; Nihal C de Lanerolle; Mark Cunningham; Tore Eid; Kristen Riley; Farah D Lubin
Journal:  Neurobiol Dis       Date:  2019-01-06       Impact factor: 5.996

2.  Multiscale Simulations of Biological Membranes: The Challenge To Understand Biological Phenomena in a Living Substance.

Authors:  Giray Enkavi; Matti Javanainen; Waldemar Kulig; Tomasz Róg; Ilpo Vattulainen
Journal:  Chem Rev       Date:  2019-03-12       Impact factor: 60.622

3.  O-GlcNAcylation regulates integrin-mediated cell adhesion and migration via formation of focal adhesion complexes.

Authors:  Zhiwei Xu; Tomoya Isaji; Tomohiko Fukuda; Yuqin Wang; Jianguo Gu
Journal:  J Biol Chem       Date:  2018-12-26       Impact factor: 5.157

4.  The putative eukaryote-like O-GlcNAc transferase of the cyanobacterium Synechococcus elongatus PCC 7942 hydrolyzes UDP-GlcNAc and is involved in multiple cellular processes.

Authors:  Kerry A Sokol; Neil E Olszewski
Journal:  J Bacteriol       Date:  2014-11-10       Impact factor: 3.490

Review 5.  Natural history of β-cell adaptation and failure in type 2 diabetes.

Authors:  Emilyn U Alejandro; Brigid Gregg; Manuel Blandino-Rosano; Corentin Cras-Méneur; Ernesto Bernal-Mizrachi
Journal:  Mol Aspects Med       Date:  2014-12-24

Review 6.  O-GlcNAcylation regulation of cellular signaling in cancer.

Authors:  Lorela Ciraku; Emily M Esquea; Mauricio J Reginato
Journal:  Cell Signal       Date:  2021-11-17       Impact factor: 4.315

Review 7.  The challenge and promise of glycomics.

Authors:  Richard D Cummings; J Michael Pierce
Journal:  Chem Biol       Date:  2014-01-16

8.  Role for high-glucose-induced protein O-GlcNAcylation in stimulating cardiac fibroblast collagen synthesis.

Authors:  Hugo Aguilar; Eduardo Fricovsky; Sang Ihm; Magdalena Schimke; Lisandro Maya-Ramos; Nakon Aroonsakool; Guillermo Ceballos; Wolfgang Dillmann; Francisco Villarreal; Israel Ramirez-Sanchez
Journal:  Am J Physiol Cell Physiol       Date:  2014-02-19       Impact factor: 4.249

9.  O-GlcNAcylation as a novel ammonia-induced posttranslational protein modification in cultured rat astrocytes.

Authors:  Ayşe Karababa; Boris Görg; Freimut Schliess; Dieter Häussinger
Journal:  Metab Brain Dis       Date:  2013-12-01       Impact factor: 3.584

10.  O-GlcNAcylation: A New Cancer Hallmark?

Authors:  Yann Fardini; Vanessa Dehennaut; Tony Lefebvre; Tarik Issad
Journal:  Front Endocrinol (Lausanne)       Date:  2013-08-12       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.